Answers are grounded in this paper and cite their sources.
The advent of Internet of Medical Things (IoMT) has made it necessary to exchange electronic health records (EHRs) across distributed healthcare entities in a manner that ensures their authentication and preserves patients’ privacy. This paper proposes the Federated and Blockchain-enabled Electronic Health Record (FBEHR) framework whose major contribution is the Improved Universal Designated Verifier Signature Proof (IUDVSP). Different from all other pairing-based UDVSP schemes, the suggested solution uses elliptic curve arithmetic compatible with ECDSA to ensure signer authenticity, designated-verifier privacy, and verification control without employing bilinear pairings. According to our experiments in the × 86 edge-server environment, IUDVSP takes 0.22 ms to generate signatures and 0.28 ms to verify them. While these results are below 2-4 ms that we take as the cost of one pairing operation in the adopted reference architecture, they are not the result of a direct same-platform performance comparison of the suggested algorithm with a complete pairing-based UDVSP protocol. The framework also features blockchain-based EHR registration, validation, access, revocation and federated ANN-LSTM-based malicious-user detection. In an internal evaluation of the suggested system, activation of edge processing results in the mean registration and validation latency reduction from 9.87 to 3.59 s which corresponds to the 62.76% latency improvement relative to the same framework but without edge processing. Performance of the FBEHR relative to existing baselines is similar; thus, the primary benefit of FBEHR is its pairing-free designated-verifier security, not latency improvement over those systems. An estimation of the total cost of ownership for a month-long period of FBEHR deployment gives us USD 1850 for the considered FBEHR architecture and USD 12,500 for the same architecture but centralized. This difference of 85.2% is calculated based on a model and is not the experimental performance cost reduction.
No takes yet. Share an insight, caveat, or question.
Chhabra et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: